Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 30, 2017 16:00 ET | Source: Incysus, Ltd

Incysus Announces Appointment of Siraj Ali, MD, PhD to Its Scientific Advisory Board

NEW YORK, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Incysus, Ltd., a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the treatment of cancers, today...
October 17, 2017 07:30 ET | Source: Incysus, Ltd

Incysus Announces FDA Approval of IND Application for a Phase 1 Study of a Gamma-Delta (γδ) T Cell Leukemia and Lymphoma Immunotherapy

-- First Clinical Trial to Test the Safety and Activity of Activated Allogeneic Donor Gamma-Delta (γδ) T cells for Cancer Immunotherapy -- NEW YORK, Oct. 17, 2017 (GLOBE NEWSWIRE) -- Incysus,...
September 19, 2017 08:00 ET | Source: Incysus, Ltd

Incysus Submits Investigational New Drug (IND) Application for Allogeneic Gamma-Delta T Cell Immunotherapy for Leukemia and Lymphoma

NEW YORK, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Incysus, Ltd., a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the treatment of cancers, today...
August 24, 2017 07:30 ET | Source: Incysus, Ltd

Incysus Announces Formation of Scientific Advisory Board

HAMILTON, Bermuda, Aug. 24, 2017 (GLOBE NEWSWIRE) -- Incysus, Ltd., a biopharmaceutical company focused on delivering an innovative γδ T cell immunotherapy for the treatment of cancers, today...
August 23, 2017 07:30 ET | Source: Incysus, Ltd

Incysus Scientific Co-Founder to Present at Immuno-Oncology Summit

HAMILTON, Bermuda, Aug. 23, 2017 (GLOBE NEWSWIRE) -- Incysus, Ltd, a biopharmaceutical company focused on delivering an innovative γδ T cell immunotherapy for the treatment of cancers, announced...
April 12, 2017 16:00 ET | Source: Incysus, Ltd

Incysus Granted European Patent Covering its Drug Resistant Immunotherapy (DRI) Technology

HAMILTON, Bermuda, April 12, 2017 (GLOBE NEWSWIRE) -- Incysus, Ltd., a biopharmaceutical company focused on delivering an innovative off-the-shelf cellular therapy for the treatment of solid tumor...
March 24, 2017 07:00 ET | Source: Incysus, Ltd

Incysus Announces Preclinical Data Presentations of γδ T Cell Immunotherapy Programs at Upcoming Medical Conferences

HAMILTON, Bermuda, March 24, 2017 (GLOBE NEWSWIRE) -- Incysus, Ltd., a biopharmaceutical company focused on delivering an innovative off-the-shelf cellular therapy for the treatment of solid tumor...